Selank

Not FDA approvedCognitive ResearchBrain, mood & sleepImmune & gut
6.8

Worth trying, BioHarmony verdict

BioHarmony score 6.8 out of 10

Selank is a synthetic tuftsin-derived heptapeptide studied as a non-sedating anxiolytic. Human evidence is positive but geographically narrow: a corrected Russian RCT in 62 patients found similar anxiolytic effects to medazepam (Zozulia 2008), while Western replication and FDA approval are absent.

Read full report

What is Selank?

Selank is a synthetic heptapeptide built from the immune peptide tuftsin plus a Pro-Gly-Pro tail. In practice, people use Selank as an intranasal anti-anxiety peptide, especially when they want calm without the sedation, amnesia, or dependence profile associated with benzodiazepines.

From the BioHarmony report, reviewed Sep 8, 2026.

Saved on this device only.

How it is thought to work

GABA-A modulation, enkephalinase inhibition, serotonin and monoamine modulation, BDNF signaling, tuftsin-class immunomodulation

Safety watch-outs

  • Paradoxical anxiety or agitation
  • Nasal irritation or infection symptoms

Full risk profile in the BioHarmony report.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

No approved-label or study protocol is recorded for Selank yet.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Educator coverage (4)

Attributed viewpoints, separate from primary research.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalNot FDA approved
CompoundingWithdrawn from Category 2 nomination; eligibility is not established

FDA identifies potential immunogenicity and peptide-impurity risks for compounded selank acetate and says human safety information is insufficient.

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.